s&o logo
  • News
  • Trade Ideas
  • Education
  • Community
Sign Up!
News

Here’s why UPS shares are trading lower today

July 23, 2024 George Levine No comments yet

United Parcel Service (NYSE: UPS) stock is lower after the company reported second-quarter financial results financial results below estimates.

What Happened: Tuesday morning, UPS reported its financial metrics for the second quarter of 2024.

  • Revenue: $21.82 billion, missing the $22.183 billion estimate
  • Adjusted EPS: $1.79, missing the $1.99 estimate

Consolidated revenues decreased 1.1% from $22.1 billion from the same period last year and adjusted EPS was 29.5% lower from the same period last year.

“This quarter was a significant turning point for our company as we returned to volume growth in the U.S., the first time in nine quarters. As expected, our operating profit declined in the first half of 2024 from what we reported last year. Going forward we expect to return to operating profit growth.”
Carol Tomé, UPS chief executive officer

The company’s U.S. domestic revenue decreased 1.9%, primarily due to a 2.6% decrease in revenue per piece due mostly to changes in product mix. International revenue decreased 1% primarily due to a 2.9% decrease in average daily volume. Supply chain solutions revenue increased 2.6% primary to growth in logistics, including healthcare.

UPS updated its full-year 2024 guidance, and now expects:

  • Consolidated revenue expected to be approximately $93.0 billion
  • Consolidated adjusted operating margin expected to be approximately 9.4%
  • Capital expenditures of approximately $4.0 billion
  • Targeting around $500 million in share repurchases

UPS shares were trading 7.84% lower to $133.80 at the time of writing. The stock has a 52-week high of $192.98 and a 52-week low of $132.90.

  • Earnings

Post navigation

Previous
Next

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

Categories

  • Education (15)
  • Featured (46)
  • News (85)
  • Trade Ideas (39)

Recent posts

  • FDA Closes Inspection of BioXcel’s TRANQUILITY II Trial Site, Reinforcing Data Integrity
  • Telomir Pharmaceuticals Breakthrough in Silver-Based Medicine
  • flyExclusive to Acquire Jet.AI’s Aviation Business in Strategic Expansion

Tags

BDRX CDT Conduit Conference Call CURR CURRENC Earnings Evergreen GH Research GHRS Grail GRAL HOLO IINN Inspira Technologies Interview IPWR JTAI KULR LCID Litigation LLY Lucid Motors M&A MedTech MicroCloud Movers MSTR My Size MYSZ News NLSP Novo Nordisk NVO Options Partnerships QNTM Quantum BioPharma Stock Market Stocks TAOP TELO Telomir Pharmaceuticals Traws Pharma TRWS

Continue reading

Featured, News, Trade Ideas

NLS Pharmaceutics and Kadimastem Move Closer to Merger Approval

January 31, 2025 Elisa Clay No comments yet

NLS Pharmaceutics (Nasdaq: NLSP) and Kadimastem (TASE: KDST) have reached a key milestone in their planned merger after Kadimastem’s shareholders approved the deal in a special general meeting. The merger aims to create a Nasdaq-listed biotechnology company with a strong portfolio of treatments for neurodegenerative diseases and diabetes. NLS is now preparing to hold its […]

Featured, News, Trade Ideas

Nukkleus Shares Surge 60% Amid Investor Optimism

January 17, 2025 Elisa Clay No comments yet

Nukkleus Inc. (NASDAQ: NUKK) saw its stock skyrocket by 60% during today’s trading session, marking a significant uptick in investor interest and market activity. The surge comes amid heightened speculation about the company’s growth prospects and potential strategic moves. While no major announcements were made by the company, the sharp increase in share price suggests […]

Featured, News, Trade Ideas

Inspira Technologies Ramps Up Production Readiness Amid hMPV Outbreak

January 10, 2025 Elisa Clay No comments yet

Inspira Technologies (Nasdaq: IINN), a leader in life-support technology innovation, has announced preparations for a potential production increase of its INSPIRA ART100 device. This proactive step comes in response to a recent outbreak of human metapneumovirus (hMPV) in China, which has brought renewed attention to the global need for advanced respiratory care solutions. The company […]

s&o logo

Our primary goal is to empower retail investors with helpful news, guides and trading ideas.

Helpful Links
  • News
  • Trade Ideas
  • Education
  • Community
Resources
  • Privacy Policy
  • Terms & Conditions
  • Contact
Get in touch
  • Email us!

© Copyright 2024, stocks&options. All Rights Reserved.